Stable pharmaceutical compositions containing a fibroblast growth factor
US5714458A · kind A · utility
10Cited by
2References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 19, 1994 |
| Grant date | Feb 3, 1998 |
| Priority date | — |
| Expiry date | Oct 19, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/1825
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A stable lyophilized formulation of a fibroblast growth factor (FGF) comprises the FGF, a pharmaceutically acceptable bulking agent and either PA1 (a) an alkali metal salt of a carboxyalkyl cellulose, or PA1 (b) a polyoxyethylene sorbitan fatty acid ester and cysteine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.